Purpose The goal of our review was to gather information on the most important community-
acquired and hospital-acquired co-infections among coronavirus disease 2019 (COVID-19) …

Patients with viral illness are at higher risk of secondary infections—whether bacterial, viral,
or parasitic—that usually lead to a worse prognosis. In the setting of Corona Virus Disease …

Background Co‐infections, secondary bacterial or fungal infections, are important risk
factors for poor outcomes in viral infections. The prevalence of co‐infection and secondary …

Objectives In previous influenza pandemics, bacterial co-infections have been a major
cause of mortality. We aimed to evaluate the burden of co-infections in patients with COVID …

Accumulating evidence shows that microbial co-infection increases the risk of disease
severity in humans. There have been few studies about SARS-CoV-2 co-infection with other …

Background At outset of the coronavirus disease 2019 (COVID-19) pandemic, the
significance of bacterial and fungal coinfections in individuals with COVID-19 was unknown …

Background Recent research highlights the contribution of co-infections to elevated disease
severity and mortality among COVID-19 patients. Given China's decision to ease epidemic …

Background We performed a nationwide population-based retrospective study to describe
the epidemiology of bacterial co-infections in coronavirus disease 2019 (COVID-19) …

The prevalence of patients hospitalized in ICUs with COVID-19 and co-infected by
pathogenic bacteria is relevant in this study, considering the integrality of treatment. This …

Background It has been recognised for a considerable time-period, that viral respiratory
infections predispose patients to bacterial infections, and that these co-infections have a …